Free Trial

Moleculin Biotech (MBRX) Short Interest Ratio & Short Volume

→ The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad)
Free MBRX Stock Alerts
$4.77
+0.13 (+2.80%)
(As of 05/31/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends

Moleculin Biotech Short Interest Data

Current Short Interest
34,200 shares
Previous Short Interest
31,100 shares
Change Vs. Previous Month
+9.97%
Dollar Volume Sold Short
$168,264.00
Short Interest Ratio
0.9 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
2,310,000 shares
Float Size
2,230,000 shares
Short Percent of Float
1.53%
Today's Trading Volume
3,871 shares
Average Trading Volume
28,392 shares
Today's Volume Vs. Average
14%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Moleculin Biotech ?

Sign up to receive the latest short interest report for Moleculin Biotech and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

MBRX Short Interest Over Time

MBRX Days to Cover Over Time

MBRX Percentage of Float Shorted Over Time

Moleculin Biotech Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/202434,200 shares $168,264.00 +10.0%1.5%0.9 $4.92
4/30/202431,100 shares $156,122.00 +16.5%1.5%0.8 $5.02
4/15/202426,700 shares $119,082.00 -40.7%1.2%0.8 $4.46
3/31/202445,000 shares $265,950.00 +2,042.9%2.1%1.4 $5.91
3/15/20242,100 shares $15,576.75 -98.4%0.1%0.1 $7.42
2/29/2024134,400 shares $84,537.60 -2.4%N/A0.8 $0.63
2/15/2024137,700 shares $68,850.00 -37.4%N/A0.9 $0.50
1/31/2024220,000 shares $110,880.00 -8.5%N/A1.2 $0.50
1/15/2024240,300 shares $170,613.00 -23.8%N/A1.3 $0.71
12/31/2023315,300 shares $270,653.52 -7.5%N/A1.6 $0.86
12/15/2023340,800 shares $197,664.00 +35.3%N/A2.1 $0.58
11/30/2023251,900 shares $150,812.53 -15.2%N/A1.7 $0.60
11/15/2023296,900 shares $169,233.00 +59.7%N/A1.9 $0.57
10/31/2023185,900 shares $90,012.78 +131.8%N/A1.5 $0.48
10/15/202380,200 shares $36,090.00 -55.3%N/A0.7 $0.45
9/30/2023179,300 shares $76,650.75 +260.0%N/A1.2 $0.43
9/15/202349,800 shares $19,770.60 +30.7%N/A0.3 $0.40
8/31/202338,100 shares $21,336.00 -75.4%N/A0.2 $0.56
8/15/2023155,100 shares $94,455.90 +15.6%N/A1 $0.61
7/31/2023134,200 shares $84,975.44 +42.6%N/A0.7 $0.63
7/15/202394,100 shares $59,283.00 -20.8%N/A0.5 $0.63
6/30/2023118,800 shares $68,761.44 +611.4%N/A0.4 $0.58
6/15/202316,700 shares $9,853.00 +108.8%N/A0.1 $0.59
5/31/20238,000 shares $5,068.00 -59.4%N/A0 $0.63
5/15/202319,700 shares $12,139.14 +20.9%N/A0.1 $0.62
4/30/202316,300 shares $12,180.99 -30.3%0.1%0.1 $0.75
4/15/202323,400 shares $21,294.00 -14.6%0.1%0.1 $0.91
3/31/202327,400 shares $26,304.00 -26.3%0.1%0.4 $0.96
3/15/202337,200 shares $35,340.00 -13.9%0.1%0.5 $0.95
2/28/202343,200 shares $52,272.00 -30.1%0.2%0.5 $1.21
2/15/202361,800 shares $80,340.00 +56.9%0.2%0.7 $1.30
1/31/202339,400 shares $49,640.06 -49.0%0.1%0.4 $1.26
1/15/202377,200 shares $100,360.00 -34.9%0.3%0.8 $1.30
12/30/2022118,600 shares $125,716.00 +48.3%0.4%1.2 $1.06
12/15/202280,000 shares $110,400.00 -9.7%0.3%0.8 $1.38
11/30/202288,600 shares $127,584.00 +30.3%0.3%0.9 $1.44
11/15/202268,000 shares $64,593.20 +32.0%0.2%0.6 $0.95
10/31/202251,500 shares $51,500.00 -9.8%0.2%0.5 $1.00
10/15/202257,100 shares $57,100.00 -5.3%0.2%0.6 $1.00
9/30/202260,300 shares $63,918.00 -36.4%0.2%0.6 $1.06
The ONE AI Stock to own now. (It’s not Nvidia.) (Ad)

Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …

Click here to see the presentation now.
9/15/202294,800 shares $134,616.00 -40.0%0.3%1 $1.42
8/31/2022158,100 shares $233,988.00 +59.2%0.6%2 $1.48
8/15/202299,300 shares $178,740.00 +85.6%0.4%2 $1.80
7/31/202253,500 shares $90,415.00 -54.7%0.2%1 $1.69
7/15/2022118,200 shares $195,467.34 +25.5%0.4%2 $1.65
6/30/202294,200 shares $136,590.00 -37.9%0.3%1.4 $1.45
6/15/2022151,600 shares $210,724.00 -39.0%0.5%1.9 $1.39
5/31/2022248,500 shares $372,750.00 +31.0%0.9%2.9 $1.50
5/15/2022189,700 shares $235,228.00 -37.0%0.7%1.9 $1.24
4/30/2022301,000 shares $478,590.00 -28.0%1.1%2.8 $1.59
4/15/2022418,300 shares $836,600.00 +0.6%1.5%3.5 $2.00
3/31/2022415,900 shares $740,302.00 -4.7%1.5%3.4 $1.78
3/15/2022436,400 shares $554,228.00 -9.6%1.6%2.4 $1.27
2/28/2022482,500 shares $670,675.00 +9.2%1.8%2.4 $1.39
2/15/2022441,900 shares $645,174.00 -9.9%1.7%1.8 $1.46
1/31/2022490,200 shares $740,202.00 -7.8%1.8%1.9 $1.51
1/15/2022531,600 shares $909,036.00 +2.0%2.0%1.9 $1.71
12/31/2021521,100 shares $969,246.00 -11.0%1.9%1.8 $1.86
12/15/2021585,400 shares $1.22 million +2.2%2.2%2.3 $2.08
11/30/2021572,600 shares $1.19 million -8.7%2.1%2.4 $2.07
11/15/2021626,800 shares $1.49 million -3.3%2.3%3.2 $2.38
10/29/2021648,000 shares $1.71 million -6.1%2.4%3.5 $2.64
10/15/2021690,400 shares $1.87 million +3.6%2.6%4 $2.71
9/30/2021666,700 shares $2.00 million -6.3%2.5%3.8 $3.00
9/15/2021711,400 shares $2.07 million -5.6%2.7%3.7 $2.91
8/31/2021753,900 shares $2.32 million +5.4%2.8%3.5 $3.08
8/13/2021715,200 shares $2.12 million -7.3%2.7%2.9 $2.97
7/30/2021771,800 shares $2.41 million -18.8%2.9%2.9 $3.12
7/15/2021949,900 shares $3.25 million -1.0%3.6%3.3 $3.42
6/30/2021959,300 shares $3.52 million +17.8%3.6%1.7 $3.67
6/15/2021814,600 shares $3.08 million -13.8%3.1%0.7 $3.78
5/28/2021944,700 shares $3.50 million -14.9%3.5%0.8 $3.70
5/14/20211,110,000 shares $3.63 million -4.3%4.2%0.9 $3.27
4/30/20211,160,000 shares $4.21 million +26.7%4.4%0.7 $3.63
4/15/2021915,500 shares $3.38 million +78.0%3.4%0.3 $3.69
3/31/2021514,200 shares $2.19 million +70.9%1.9%0.2 $4.25
3/15/2021300,800 shares $1.34 million -50.1%1.1%0.1 $4.44
2/26/2021602,500 shares $2.62 million +44.7%2.6%0.3 $4.35
2/12/2021416,500 shares $2.23 million -84.9%1.8%0.2 $5.36
1/29/20212,760,000 shares $16.06 million +8.2%12.6%1.4 $5.82
1/15/20212,550,000 shares $15.45 million +4.9%N/A1 $6.06
12/31/20202,430,000 shares $12.17 million +4.7%N/A1.2 $5.01
12/15/20202,320,000 shares $10.75 million -0.4%N/A1.6 $4.63
11/30/20202,330,000 shares $10.82 million -7.2%N/A1.7 $4.64
11/15/20202,510,000 shares $11.58 million -3.5%N/A5 $4.61
10/30/20202,600,000 shares $11.23 million -11.3%N/A4.9 $4.32
10/15/20202,930,000 shares $14.29 million -5.5%N/A4.1 $4.88
9/30/20203,100,000 shares $15.12 million +2.0%N/A1 $4.88
9/15/20203,040,000 shares $14.85 million -10.3%N/A1 $4.88
8/31/20203,390,000 shares $17.83 million -7.6%N/A1.1 $5.26
Biden Nomination CANCELED? (Ad)

The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?

I believe I have the terrifying answer right here.
8/14/20203,670,000 shares $21.58 million -5.4%N/A1.1 $5.88
7/31/20203,880,000 shares $26.77 million +19.0%N/A1.2 $6.90
7/15/20203,260,000 shares $20.93 million -11.7%N/A1 $6.42
6/30/20203,690,000 shares $21.43 million -13.2%N/A0.7 $5.81
6/15/20204,250,000 shares $28.56 million -3.2%N/A0.8 $6.72
5/29/20204,390,000 shares $28.71 million +8.7%N/A0.7 $6.54
5/15/20204,040,000 shares $25.94 million -28.2%N/A0.7 $6.42
4/30/20205,630,000 shares $36.82 million +10.8%N/A1 $6.54
4/15/20205,080,000 shares $38.40 million +213.6%N/A0.9 $7.56
3/31/20201,620,000 shares $1.85 million +202.9%N/A0.4 $1.14
3/13/2020534,900 shares $604,437.00 -27.4%1.4%1.5 $1.13
2/28/2020736,300 shares $404,965.00 -35.4%1.9%1.1 $0.55
2/14/20201,140,000 shares $649,800.00 -16.8%2.9%1.8 $0.57
1/31/20201,370,000 shares $945,300.00 -4.2%3.5%2.5 $0.69
1/15/20201,430,000 shares $1.07 million -20.1%3.7%6.1 $0.75
12/31/20191,790,000 shares $1.68 million -6.3%4.6%7.8 $0.94

MBRX Short Interest - Frequently Asked Questions

What is Moleculin Biotech's current short interest?

Short interest is the volume of Moleculin Biotech shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 34,200 shares of MBRX short. 1.53% of Moleculin Biotech's shares are currently sold short. Learn More on Moleculin Biotech's current short interest.

What is a good short interest ratio for Moleculin Biotech?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MBRX shares currently have a short interest ratio of 1.0. Learn More on Moleculin Biotech's short interest ratio.

What is a good short interest percentage for Moleculin Biotech?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.53% of Moleculin Biotech's floating shares are currently sold short.

Is Moleculin Biotech's short interest increasing or decreasing?

Moleculin Biotech saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 34,200 shares, an increase of 10.0% from the previous total of 31,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Moleculin Biotech's float size?

Moleculin Biotech currently has issued a total of 2,310,000 shares. Some of Moleculin Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Moleculin Biotech currently has a public float of 2,230,000 shares.

How does Moleculin Biotech's short interest compare to its competitors?

1.53% of Moleculin Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Moleculin Biotech: NextCure, Inc. (0.43%), HCW Biologics Inc. (0.01%), Daré Bioscience, Inc. (0.53%), NRx Pharmaceuticals, Inc. (7.00%), Acurx Pharmaceuticals, Inc. (4.43%), Reviva Pharmaceuticals Holdings, Inc. (6.38%), DURECT Co. (3.13%), VYNE Therapeutics Inc. (0.46%), Eyenovia, Inc. (10.27%), Cara Therapeutics, Inc. (5.23%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short Moleculin Biotech stock?

Short selling MBRX is an investing strategy that aims to generate trading profit from Moleculin Biotech as its price is falling. MBRX shares are trading up $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Moleculin Biotech?

A short squeeze for Moleculin Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MBRX, which in turn drives the price of the stock up even further.

How often is Moleculin Biotech's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MBRX, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

Related Companies:
Short Interest Tools:
This page (NASDAQ:MBRX) was last updated on 6/1/2024 by MarketBeat.com Staff

From Our Partners
The #1 Crypto That You Don’t Own… Yet
Crypto 101 Media
Biden Nomination CANCELED?
The Freeport Society
On June 10, Nvidia makes its next big move
Weiss Ratings
MAJOR BUY SIGNAL: Move Fast, Washington/Pelosi/Mill…
Altimetry
Unlock Explosive Gains with This Defense Stock
Behind the Markets
Must-See: Elon’s New Invention is Absolutely Insane
InvestorPlace
Claim Your Complimentary Bitcoin Reward
Crypto Swap Profits
Trump’s Gift Could Unleash $51 Billion in New Wealth
Wealthpin Pro